Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 10—October 2006

Chikungunya Virus Strains, Reunion Island Outbreak

On This Page
Article Metrics
citations of this article
EID Journal Metrics on Scopus

Cite This Article

To the Editor: Chikungunya virus (CHIKV) is endemic in rural tropical Africa and is penetrating urban areas in Asia. CHIKV is maintained in a sylvatic cycle that involves mosquitoes of the genus Aedes, primates, and rodents. CHIKV infection induces fever, arthralgia, and maculopapular rash. Hemorrhagic complications have been reported in some outbreaks, but a more specific symptom is severe arthralgia, often persistent, which results in long-lasting disability.

After numerous cases of CHIKV infection had been reported in Comoros and Mauritius (1), an outbreak of febrile illness was reported on Reunion Island in March 2005 (2). The incidence of the disease remained relatively low until December 2005, when it increased dramatically. The outbreak resulted in >3,500 confirmed cases and an estimated 250,000 suspected cases (2), affecting >25% of the island's inhabitants. Encephalitic forms were reported on many occasions during the active phase of the outbreak, and >200 persons died while they were infected with CHIKV. Previously unreported complications, such as mother-to-child transmission, myocarditis, hepatitis, and extensive dermal lesions were also encountered.

Many samples, collected from patients during the outbreak, were sent to our laboratory (Virology Unit, Tropical Institute of the French Armed Forces Medical Service, Marseille, France) to identify the etiologic agent. Serum samples incubated with C6/36 cells according to previously published methods (3) yielded CHIKV. This virus was also isolated from cerebrospinal fluid collected from a patient with encephalitis, from corneas collected from asymptomatic human organ donors, and from pools of mosquitoes (Aedes albopictus and Culex quinquefasciatus) collected on the island.

Five isolates were partially sequenced. The CHIKV genome was partly amplified by using the specific primer pair OP16/OP17 (4), and reverse transcription (RT)-PCR products (1,200 nucleotides long) were cloned and sequenced (GenBank accession nos. DQ462746–DQ462750). Comparison of partial sequences showed a high degree of identity between the strains isolated in Reunion, including the strain LR2006_OPY1 (5): paired identity was 99.3%–100% at the nucleotide level and 98.2%–100% at the amino acid level. The nucleotide and amino acid substitutions were homogeneously distributed across the sequence and were different for each isolate. Our strain IMT/6470, isolated from human serum, and the strain LR2006_OPY1 displayed the same nucleotide sequence in the sequenced region. The sequence identity among these isolates highlights the common origin of human and mosquito isolates.

The sequences of our isolates did not feature any codon deletions or insertions when compared with other CHIKV isolates from Africa and Asia available in GenBank (4,6). Strains from Reunion were also compared with the candidate vaccine strain TSI-GSD-218 (7). This strain showed 93%–94% and 96%–97% identity at the nucleotide and amino acid level, respectively, which suggests a sufficient antigenic community. Nevertheless, cross-neutralization experiments are necessary to confirm the protective effect of this candidate vaccine against Reunion strains.


Thumbnail of Phylogenetic tree of chikungunya virus (CHIKV) based on partial nucleotide sequences (3´ extremity of E1/3´ untranslated, position 10238–11367). Phylogram was constructed with MEGA 2 (, and the tree was drawn with the Jukes-Cantor algorithm for genetic distance determination and the neighbor-joining method. The percentage of successful bootstrap replicates (1,000 bootstrap replications, confidence probability >90%) is indicated at nodes. The len

Figure. Phylogenetic tree of chikungunya virus (CHIKV) based on partial nucleotide sequences (3´ extremity of E1/3´ untranslated, position 10238–11367). Phylogram was constructed with MEGA 2 (, and the tree was drawn...

In the phylogenetic tree based on the partial E1 sequences (Figure), all CHIKV strains isolated in Reunion clustered together. These strains were closely related to strains from the Central African Republic and the Democratic Republic of Congo (4,6). This finding suggests that the boundaries of the Central African CHIKV strains now extend to the Indian Ocean. The phylogenetic tree also illustrates the difference of lineage between the Reunion Island isolates and the Asian isolates.

CHIKV has been isolated from Culex spp. collected during outbreaks (8), but laboratory experiments have shown that Cx. quinquefasciatus failed to transmit CHIKV to monkeys (9). Inside the Reunion cluster, the strain from Culex spp. was localized in a separate branch (bootstrap value 100%); this finding could be relevant to the different role of these mosquito species in virus epidemiology.

To our knowledge, CHIKV has never been isolated from human corneas. In our study, the cornea sample was obtained from an asymptomatic donor whose serum contained immunoglobulin M (IgM) but not IgG to CHIKV; this finding suggests the patient was recently infected with CHIKV. The presence of CHIKV in corneal cells will have to be confirmed because the samples we studied also included sclera, vascular tissue that could contain circulating virions; however, no virus was detected in the patient's blood sample by CHIKV-specific RT-PCR assay (10). Infected corneal or scleral cells may constitute a sanctuary that allows virus to persist after virus is no longer present in blood. Because viral persistence, which could explain long-lasting clinical complications of CHIKV infection, has never been demonstrated, this question deserves more investigation.

Our results indicate that CHIKV strains responsible for the outbreak in Reunion have a common origin and do not differ from strains circulating in East and Central Africa. More complete characterization of the 5 strains we report here, sequencing of the full-length genome, and phenotypic characterization of other CHIKV isolated in the area during the same period is currently underway in our laboratory.



We are indebted to Jean-Marie Milleliri for advice; Jon M. Davis for reviewing the paper; and Patrick Gravier, Christophe N'Guyen, and Yannick Sanson for excellent technical assistance.


Maël Bessaud*, Christophe N. Peyrefitte*†, Boris A.M. Pastorino*, Fabienne Tock*, Olivier Merle*, Jean-Jacques Colpart‡, Jean-Sébastien Dehecq§, Romain Girod*, Marie-Christine Jaffar-Bandjee¶, Pamela J. Glass#, Michael Parker#, Hugues J. Tolou*, and Marc Grandadam*Comments to Author 
Author affiliations: *Institut de médecine tropicale du Service de santé des armées, Marseille, France; †Walter Reed Army Institute of Research, Silver Spring, Maryland, USA; ‡Agence de la biomédecine, Lyon, France; §Direction régionale des affaires sanitaires et sociales, Saint-Denis, Île de la Réunion, France; ¶Centre hospitalier départemental Félix-Guyon, Saint-Denis, Île de la Réunion, France; #United States Army Medical Research Institute for Infectious Diseases, Fort Detrick, Maryland, USA



  1. World Health Organization. Chikungunya in La Reunion Island (France) 2006 Feb 17 [cited 2006 Aug 1]. Available from
  2. La Réunion-Mayotte  CIRE. Epidémie de chikungunya à la Réunion. Point hebdomadaire, semaine 13. 2006 Apr 6 [cited 2006 Aug 7]. Available from
  3. Peyrefitte  CN, Pastorino  BAM, Bessaud  M, Gravier  P, Tock  F, Couissinier-Paris  P, Dengue type 3 virus, Saint Martin, 2003–2004. Emerg Infect Dis. 2005;11:75761.PubMedGoogle Scholar
  4. Pastorino  B, Muyembe-Tamfum  JJ, Bessaud  M, Tock  F, Tolou  H, Durand  JP, Epidemic resurgence of chikungunya virus in Democratic Republic of the Congo: identification of a new Central African strain. J Med Virol. 2004;74:27782. DOIPubMedGoogle Scholar
  5. Charrel  R, Lamballerie  X. Reunion sequence. ProMed. 2006 Mar 23. Available from, archive no. 20060323.0896.
  6. Powers  AM, Brault  AC, Tesh  RB, Weaver  SC. Re-emergence of chikungunya and o'nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J Gen Virol. 2000;81:4719.PubMedGoogle Scholar
  7. Edelman  R, Tacket  CO, Wasserman  SS, Bodinson  SA, Perry  JG, Mangiafico  JA. Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. Am J Trop Med Hyg. 2000;62:6815.PubMedGoogle Scholar
  8. Vaucel  M. Affections dues aux virus: chapitre VII. Affections à virus neurotropes. In: Médecine tropicale. Paris: Editions Médicales Flammarion; 1966. p. 1111–7.
  9. Jupp  PG, McIntosh  BM, dos Santos  I, DeMoor  P. Laboratory vector studies on six mosquito and one tick species with chikungunya virus. Trans R Soc Trop Med Hyg. 1981;75:159. DOIPubMedGoogle Scholar
  10. Pastorino  B, Bessaud  M, Grandadam  M, Murri  S, Tolou  HJ, Peyrefitte  CN. Development of a TaqMan RT-PCR assay without RNA extraction step for the detection and quantification of African chikungunya viruses. J Virol Methods. 2005;124:6571. DOIPubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid1210.060596

Related Links


Table of Contents – Volume 12, Number 10—October 2006

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Marc Grandadam, Unité de Virologie Tropicale, IMTSSA, BP 46, 13 998 Marseille Armées, France

Send To

10000 character(s) remaining.


Page created: November 10, 2011
Page updated: November 10, 2011
Page reviewed: November 10, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.